Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefan Wachter

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Oncology|September 2, 2003
Neoadjuvant hormonal treatment and radiotherapy for prostate cancerStefan Wachter, Natascha Wachter-Gerstner, Richard Pötter
Frontiers of Radiation Therapy and Oncology|February 15, 2002
Planning target volume and dose prescription in definitive radiotherapy for prostate cancer with favourable prognostic factorsStefan Wachter, Natascha Gerstner, Ulrike Mock, et al.
Nature Communications|April 12, 2017
A microprocessor based on a two-dimensional semiconductorStefan Wachter, Dmitry K Polyushkin, Ole Bethge, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|October 19, 2002
Biochemical response after 3-d conformal radiotherapy of localized prostate cancer to a total dose of 66 gy 4-year resultsNatascha Wachter-Gerstner, Stefan Wachter, Gregor Goldner, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|September 1, 2006
Long-term results in three-dimensional conformal radiotherapy of localized prostate cancer at moderate dose (66 Gy)Gregor Goldner, Stefan Wachter, Natascha Wachter-Gerstner, et al.
Wiener Klinische Wochenschrift|November 29, 2007
[Permanent interstitial brachytherapy (seeds) for patients with primary localized prostate cancer: analysis of 100 patients]Gregor Goldner, Nevin Ozdemiroglu, Stefan Wachter, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|May 13, 2003
Acute side effects during 3-D-planned conformal radiotherapy of prostate cancer. Differences between patient's self-reported questionnaire and the corresponding doctor's reportGregor Goldner, Natascha Wachter-Gerstner, Stefan Wachter, et al.
International Journal of Radiation Oncology, Biology, Physics|January 5, 2002
The influence of a rectal balloon tube as internal immobilization device on variations of volumes and dose-volume histograms during treatment course of conformal radiotherapy for prostate cancerStefan Wachter, Natascha Gerstner, Daniela Dorner, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 30, 2003
The impact of sectional imaging on dose escalation in endocavitary HDR-brachytherapy of cervical cancer: results of a prospective comparative trialNatascha Wachter-Gerstner, Stefan Wachter, Evi Reinstadler, et al.
Nature Communications|February 8, 2018
Optical imaging of strain in two-dimensional crystalsLukas Mennel, Marco M Furchi, Stefan Wachter, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Oncology|September 2, 2003
Neoadjuvant hormonal treatment and radiotherapy for prostate cancerStefan Wachter, Natascha Wachter-Gerstner, Richard Pötter
Frontiers of Radiation Therapy and Oncology|February 15, 2002
Planning target volume and dose prescription in definitive radiotherapy for prostate cancer with favourable prognostic factorsStefan Wachter, Natascha Gerstner, Ulrike Mock, et al.
Nature Communications|April 12, 2017
A microprocessor based on a two-dimensional semiconductorStefan Wachter, Dmitry K Polyushkin, Ole Bethge, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|October 19, 2002
Biochemical response after 3-d conformal radiotherapy of localized prostate cancer to a total dose of 66 gy 4-year resultsNatascha Wachter-Gerstner, Stefan Wachter, Gregor Goldner, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|September 1, 2006
Long-term results in three-dimensional conformal radiotherapy of localized prostate cancer at moderate dose (66 Gy)Gregor Goldner, Stefan Wachter, Natascha Wachter-Gerstner, et al.
Wiener Klinische Wochenschrift|November 29, 2007
[Permanent interstitial brachytherapy (seeds) for patients with primary localized prostate cancer: analysis of 100 patients]Gregor Goldner, Nevin Ozdemiroglu, Stefan Wachter, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|May 13, 2003
Acute side effects during 3-D-planned conformal radiotherapy of prostate cancer. Differences between patient's self-reported questionnaire and the corresponding doctor's reportGregor Goldner, Natascha Wachter-Gerstner, Stefan Wachter, et al.
International Journal of Radiation Oncology, Biology, Physics|January 5, 2002
The influence of a rectal balloon tube as internal immobilization device on variations of volumes and dose-volume histograms during treatment course of conformal radiotherapy for prostate cancerStefan Wachter, Natascha Gerstner, Daniela Dorner, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 30, 2003
The impact of sectional imaging on dose escalation in endocavitary HDR-brachytherapy of cervical cancer: results of a prospective comparative trialNatascha Wachter-Gerstner, Stefan Wachter, Evi Reinstadler, et al.
Nature Communications|February 8, 2018
Optical imaging of strain in two-dimensional crystalsLukas Mennel, Marco M Furchi, Stefan Wachter, et al.
Pageof 3